Schedule 13G ownership disclosure

Ocular Therapeutix Inc

Common Stock, $0.0001 par value per share · CUSIP: 67576A100

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 12,913,420.00 · Class: 7.3%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 12,913,420.00 · Class: 7.3%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 12,913,420.00 · Class: 7.3%

  • VHCP Management III, LLC

    Shares: 12,913,420.00 · Class: 7.3%

  • VHCP Management EG, LLC

    Shares: 12,913,420.00 · Class: 7.3%

  • Nimish Shah

    Shares: 12,913,420.00 · Class: 7.3%

  • Bong Y. Koh

    Shares: 12,913,420.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001738048-25-000020
Form type
SCHEDULE 13G/A
Filer
OCULAR THERAPEUTIX, INC
CIK
CIK 1393434
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub